InvestorsHub Logo
Followers 17
Posts 343
Boards Moderated 0
Alias Born 07/01/2008

Re: clambottler post# 149482

Monday, 03/01/2021 11:27:50 PM

Monday, March 01, 2021 11:27:50 PM

Post# of 233768
Bruce Patterson Continues his PATENT FILING - ADDED MORE since the CYDY Patent over the CCR5 ASSAY

Remember this Patent controlling --- that CYDY has to deal with

IncellDx Files Patent for CCL5/RANTES Utility as a Diagnostic, Prognostic, and Therapeutic Biomarker in COVID-19 and Other Cytokine Storm Conditions
Company files Pre-EUA with FDA for CCR5 Receptor Occupancy and COVID cytokine panel including IL-6, IL-8,TNF-a, GM-CSF, and CCL5/RANTES


Did you see his new patents too --- ???


See Bruce and Incell DX

SAN CARLOS, Calif., Feb. 3, 2021 /PRNewswire/ -- IncellDx, a leading precision medicine diagnostics company, has filed patents for algorithms identifying immunologic profiles unique to COVID long haulers and patients with severe COVID.

IncellDx has developed and patented two distinct algorithms using machine learning, built on a tailored panel of cytokines and chemokines specific for abnormalities in cytokine storm conditions and in chronic COVID patients (often referred to as COVID "long haulers"). These have been submitted for publication (pre-print available through BioRx https://www.biorxiv.org/content/10.1101/2020.12.16.423122v1).




Patterson has really stepped up in controlling the field.


Seems like these other companies have to come begging.


xxx.
xx.
x.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News